Aspermytin A

Details

Top
Internal ID 4b864b47-ff48-4b65-bec2-c171940fea29
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbonyl compounds > Ketones > Beta-hydroxy ketones
IUPAC Name 1-[(1R,2R,4aR,6S,8aS)-2-hydroxy-1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydronaphthalen-1-yl]-3-hydroxypropan-1-one
SMILES (Canonical) CC1CCC2C(C1)C=CC(C2(C)C(=O)CCO)(C)O
SMILES (Isomeric) C[C@H]1CC[C@H]2[C@H](C1)C=C[C@@]([C@]2(C)C(=O)CCO)(C)O
InChI InChI=1S/C16H26O3/c1-11-4-5-13-12(10-11)6-8-15(2,19)16(13,3)14(18)7-9-17/h6,8,11-13,17,19H,4-5,7,9-10H2,1-3H3/t11-,12-,13-,15+,16-/m0/s1
InChI Key RYBXJAJHOPCXHS-RDUHTLEXSA-N
Popularity 6 references in papers

Physical and Chemical Properties

Top
Molecular Formula C16H26O3
Molecular Weight 266.38 g/mol
Exact Mass 266.18819469 g/mol
Topological Polar Surface Area (TPSA) 57.50 Ų
XlogP 2.50
Atomic LogP (AlogP) 2.32
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 3

Synonyms

Top
(+)-Aspermytin A
CHEMBL4162012
CHEBI:181609
AKOS040738534
NCGC00380110-01
1-[(1R,2R,4aR,6S,8aS)-2-hydroxy-1,2,6-trimethyl-4a,5,6,7,8,8a-hexahydronaphthalen-1-yl]-3-hydroxypropan-1-one
NCGC00380110-01_C16H26O3_1-Propanone, 3-hydroxy-1-[(1R,2R,4aR,6S,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2-hydroxy-1,2,6-trimethyl-1-naphthalenyl]-

2D Structure

Top
2D Structure of Aspermytin A

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9946 99.46%
Caco-2 + 0.8810 88.10%
Blood Brain Barrier + 0.6000 60.00%
Human oral bioavailability - 0.5000 50.00%
Subcellular localzation Mitochondria 0.6948 69.48%
OATP2B1 inhibitior - 0.8562 85.62%
OATP1B1 inhibitior + 0.8955 89.55%
OATP1B3 inhibitior + 0.9498 94.98%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior + 0.5734 57.34%
BSEP inhibitior - 0.7005 70.05%
P-glycoprotein inhibitior - 0.9573 95.73%
P-glycoprotein substrate - 0.8042 80.42%
CYP3A4 substrate + 0.6076 60.76%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8462 84.62%
CYP3A4 inhibition - 0.6701 67.01%
CYP2C9 inhibition - 0.8168 81.68%
CYP2C19 inhibition - 0.8665 86.65%
CYP2D6 inhibition - 0.9457 94.57%
CYP1A2 inhibition - 0.6632 66.32%
CYP2C8 inhibition - 0.8231 82.31%
CYP inhibitory promiscuity - 0.8911 89.11%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9100 91.00%
Carcinogenicity (trinary) Non-required 0.6470 64.70%
Eye corrosion - 0.9913 99.13%
Eye irritation - 0.9540 95.40%
Skin irritation - 0.5226 52.26%
Skin corrosion - 0.9699 96.99%
Ames mutagenesis - 0.6837 68.37%
Human Ether-a-go-go-Related Gene inhibition - 0.5252 52.52%
Micronuclear - 0.9500 95.00%
Hepatotoxicity + 0.5660 56.60%
skin sensitisation - 0.7996 79.96%
Respiratory toxicity - 0.5000 50.00%
Reproductive toxicity + 0.7222 72.22%
Mitochondrial toxicity + 0.7500 75.00%
Nephrotoxicity - 0.8090 80.90%
Acute Oral Toxicity (c) III 0.7752 77.52%
Estrogen receptor binding - 0.6537 65.37%
Androgen receptor binding - 0.5566 55.66%
Thyroid receptor binding + 0.6380 63.80%
Glucocorticoid receptor binding - 0.5524 55.24%
Aromatase binding + 0.5867 58.67%
PPAR gamma - 0.7691 76.91%
Honey bee toxicity - 0.8472 84.72%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.6000 60.00%
Fish aquatic toxicity + 0.9520 95.20%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 99.05% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.10% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.42% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 86.01% 100.00%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 85.67% 91.11%
CHEMBL221 P23219 Cyclooxygenase-1 82.86% 90.17%
CHEMBL4227 P25090 Lipoxin A4 receptor 82.51% 100.00%

Cross-Links

Top
PubChem 9993091
NPASS NPC62049
LOTUS LTS0143959
wikiData Q77483525